COSM — Cosmos Health Inc.
—
Nasdaq ·
Consumer Discretionary ·
Distributors ·
CIK 1474167 ·
Last close
$0.31
Market Cap
$31.64M
52W High
$1.32
52W Low
$0.16
ADV30
3,799,260
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 18,986,376 | 1,511,662 | -2,925,607 | -6,086,522 | 61,461,954 | 1,800,949 | 40,787,471 |
| Mar 2026 | 17,927,892 | 1,381,171 | -2,184,179 | -2,805,423 | 62,369,011 | 514,702 | 42,542,652 |
| Dec 2025 | 19,703,160 | 2,079,344 | -11,243,640 | -10,145,943 | 65,477,518 | 715,674 | 47,052,889 |
| Sep 2025 | 17,110,425 | 2,602,618 | -1,818,715 | -5,352,890 | 69,492,758 | 889,441 | 46,357,874 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,328,363
Investing CF
$-2,716,749
Financing CF
$13,842,856
CapEx
$-150,414
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.36
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-135,972,696
Inventory
$5,650,458
Receivables
$21,037,783
ST Investments
$34,225
EBIT TTM
$-17,883,217
Pretax Income TTM
$-21,132,324
Interest Exp TTM
$3,249,107
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$73,727,856
EBITDA
$-16,787,216
Free Cash Flow
$-10,067,404
Enterprise Value
$39,658,432
Total Cash
$1,838,413
Total Debt
$15,976,119
Shares Out
100,633,773
Trailing EPS
$-0.67
Book Value
$0.26
ROE
-104.0%
ROA
-18.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 65,271,815 | -16,540,819 | -19,144,998 | 65,477,518 | 47,052,889 | 18,424,629 | -8,447,614 |
| Dec 2024 | 54,426,402 | -15,252,850 | -16,183,018 | 54,311,892 | 29,778,963 | 24,532,929 | -7,717,034 |
| Dec 2023 | 53,376,874 | -21,831,217 | -18,542,654 | 66,014,811 | 29,971,783 | 36,043,028 | -15,635,999 |
| Dec 2022 | 50,347,652 | -7,474,036 | -13,830,371 | 68,038,621 | 28,381,912 | 39,656,709 | -14,870,639 |
TTM Snapshot
Revenues TTM
$69,487,179
NetIncome TTM
$-21,132,324
OpCashFlow TTM
—
Assets (Latest)
$62,369,011
Forward EPS
$0.07
Max Pain — expiry 2027-01-15
max pain strike: $0.50 · spot: $0.34 · call oi: 3,957 · put oi: 98
Expected Move to 2027-01-15:
±$0.33
(98.21%) —
implied range
$0.01 –
$0.68
· ATM straddle on $0.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RAVE | RAVE RESTAURANT GROUP, INC. | $31.83M | $2.24 | — |
| ACH | ACCENDRA HEALTH INC/VA/ | $34.08M | $0.44 | — |
| MWYN | Marwynn Holdings, Inc. | $27.87M | $1.38 | — |
| FSTJ | First America Resources Corp | $42.57M | $0.48 | — |
| SPRS | SURGE COMPONENTS INC | $22.89M | $3.99 | — |
News headlines (Yahoo Finance, 1h cache)
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
2026-10-07 13:30 · Yahoo
COSM Continues to Surge Revenue Growth
2026-10-07 13:14 · Yahoo
COSM Continues to Grow Business
2026-09-29 17:03 · Yahoo
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
2026-09-28 12:00 · Yahoo
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
2026-09-15 14:30 · Yahoo
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
2026-09-11 15:10 · Yahoo
COSM Again Expands its Market and Accelerates its Growth
2026-09-10 12:11 · Yahoo
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
2026-09-09 13:30 · Yahoo
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
2026-08-28 13:30 · Yahoo
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
2026-08-24 19:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.